RT Journal Article
SR Electronic
T1 Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.12.21266183
DO 10.1101/2021.11.12.21266183
A1 Rachael Pung
A1 Josh A Firth
A1 Lewis G Spurgin
A1 Singapore CruiseSafe working group
A1 CMMID COVID-19 working group
A1 Vernon J Lee
A1 Adam J Kucharski
YR 2021
UL http://medrxiv.org/content/early/2021/11/14/2021.11.12.21266183.abstract
AB The emergence of the highly transmissible SARS-CoV-2 Delta variant has created a need to reassess the risk posed by increasing social contacts as countries resume pre-pandemic activities, particularly in the context of resuming large-scale events over multiple days. To examine how social contacts formed in different activity settings influences interventions required to control outbreaks, we combined high-resolution data on contacts among passengers and crew on cruise ships with network transmission models. We found passengers had a median of 20 (IQR 10–36) unique close contacts per day, and over 60% of their contact episodes were made in dining or sports areas where mask wearing is typically limited. In simulated outbreaks, we found that vaccination coverage and rapid antigen tests had a larger effect than mask mandates alone, indicating the importance of combined interventions against Delta to reduce event risk in the vaccine era.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRP declares funding from the Singapore Ministry of Health. AJK declares funding from Wellcome Trust ((206250/Z/17/Z) and the National Institute of Health Research (NIHR)(NIHR200908).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London School of Hygiene and Tropical Medicine Ethics CommitteeI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://github.com/rachaelpung/cruise_networks https://github.com/rachaelpung/cruise_networks